Onyvax Company
Onyvax develops cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells.
Technology:
Whole-Cell Antigens
Industry:
Whole-Cell Antigens
Headquarters:
Bradford, Somerset, United Kingdom
Founded Date:
1997-01-01
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investors Number:
5
Total Funding:
29800000
Last Funding Date:
2006-05-08
Last Funding Type:
Series C
Register and Claim Ownership